ACU vs GSK · P/E 19, rev $115.0M vs P/E 13, $103.31B cap
Acme United Corporation (ACU) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Acme United Corporation (ACU) is a household & personal products company listed on AMEX.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ACU revenue for 2026-06-30 was $115.0M. Net income was $6.0M. ACU currently screens at market cap $168.8M and trailing P/E 19.1.
GSK does not have a complete income-statement cache yet.
ACU currently screens at market cap $168.8M and trailing P/E 19.1. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ACU and GSK stock pages for the full models.
Not investment advice.